Could Pfizer's Paxlovid or other antivirals help cure long COVID?

Could Pfizer's Paxlovid or other antivirals help cure long COVID?

Source: 
Fierce Pharma
snippet: 

While the biopharmaceutical industry has been quick to develop vaccines, antibodies and antiviral remedies to combat the coronavirus, one area that has remained elusive for researchers is long COVID.


It hasn’t been for lack of trying. In February of 2021, the National Institutes of Health launched a four-year study backed by $1.15 billion in funding. Meanwhile, bits of anecdotal evidence give hope to those who have been brought down by the condition that treatment may be on its way.